SCHEMBL3393791

SCHEMBL3393791

CCN1C(=O)SC(=Cc2cn(-c3ccccc3)nc2-c2cc(F)cc(F)c2)C1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
GLA P06280 1/20 0.59
ENPP3 O14638 1/20 0.54
POLB P06746 1/20 0.54
CDC25B P30305 2/20 0.54
PTPN1 P18031 5/20 0.52
MAPT P10636 1/20 0.52
PKM P14618 1/20 0.52
MAPK1 P28482 1/20 0.52
GALK1 P51570 1/20 0.52
MCL1 Q07820 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
PTPN2 P17706 1/20 0.51
PTPN6 P29350 1/20 0.51
PTPN11 Q06124 1/20 0.51
HIF1AN Q9NWT6 1/20 0.51
PTGES O14684 1/20 0.50
DNMT1 P26358 1/20 0.49
DUSP3 P51452 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3393782 1.00 MEN1 (0.59) MEN1KMT2AGLAENPP3POLB
SCHEMBL3391181 0.87 CDC25B (0.63) MEN1KMT2AGLAPOLBCDC25B
SCHEMBL3391174 0.87 CDC25B (0.63) MEN1KMT2AGLAPOLBCDC25B
SCHEMBL3388931 0.80 CDC25B (0.83) MEN1KMT2AGLAPOLBCDC25B
SCHEMBL3388927 0.80 CDC25B (0.83) MEN1KMT2AGLAPOLBCDC25B
SCHEMBL8377947 0.80 MEN1 (0.84) MEN1KMT2AGLAENPP3POLB
SCHEMBL3391172 0.78 PTGES (0.53) MEN1KMT2APOLBMAPTMAPK1
SCHEMBL3391167 0.78 PTGES (0.53) MEN1KMT2APOLBMAPTMAPK1
SCHEMBL8374549 0.77 KMT2A (0.67) MEN1KMT2AGLAPOLBCDC25B
SCHEMBL27440675 0.77 PTGES (0.66) MEN1KMT2AGLAPTPN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861395-B1 5-(1,3-DIARYL-1H-PYRAZOL-4-YLMETHYLENE)-THIAZOLIDINE-2,4-DIONE DERIVATIVES USEFUL AS ANTICANCER AGENT KOREA RES INST CHEM TECH (KR) 2010-12-29 EP disclosed
US-7718681-B2 5-(1,3-Diaryl-1H-pyrazol-4-ylmethylene)-thiazolidine,2,4-dione derivatives useful as anticancer agent KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-05-18 US disclosed
US-20080275094-A1 5-(1,3-Diaryl-1H-Pyrazol-4-1 Methylene)-Thiazolidine-2,4-Dione Derivatives Useful as Anticancer Agent BARCLAYS BANK PLC (GB) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275094-A1 5-(1,3-Diaryl-1H-Pyrazol-4-1 Methylene)-Thiazolidine-2,4-Dione Derivatives Useful as Anticancer Agent TP53, CDKN1A, API5 MEN1 1251/4885KMT2A 1855/4885GLA 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.